Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck extends I/O lead as EU Oks Keytruda in first line lung cancer

biopharmadiveSeptember 17, 2018

Tag: NSCLC , lung cancer , immunotherapy , Opdivo , Keytruda

PharmaSources Customer Service